Platelet-rich preparations as biocarriers for local drugs for periodontal disease: A narrative review


Ercan E., Çiçekliyurt M. M.

Saudi Journal of Oral Sciences, cilt.10, sa.3, ss.129-135, 2023 (Hakemli Dergi)

Özet

secondary functions such as angiogenesis and innate immunity.

Aims: This review focuses on different methods of platelet‑rich plasma production and its use as a drug carrier, particularly in

dental medicine.

Materials and Methods: Scientific databases were searched from 2006 to 2013.

Results and Discussion: Platelet‑derived growth factors are released during the modulation of the wound‑healing process

and regulate many biological activities. High regeneration capacity in the wound healing process combines its use with

traditional methods in medical applications and sometimes in alternative treatment methods. Platelet‑rich biological structures

have advantages such as rapid and easy production, antimicrobial properties, high regenerative capacity, and inhibition of

postoperative bleeding. Platelet‑rich autogenous blood concentrates can administer antibiotics and anti‑inflammatory drugs

locally. Platelet‑rich biological structures can also be used as high‑quality carriers for the targeted delivery of drugs.

Conclusion: Apart from antibiotics, orally administered analgesics, anticancer drugs, etc., can also be added to platelet‑rich fibrin

because the three‑dimensional fibrin matrix structure undergoes fibrinolysis completely autogenously within the body. Still,

biocompatibility, biodegradability, mechanical strength, and shape retention must be investigated for optimal drug utilization.